Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
clinical trials
fda
2
×
givosiran
2
×
life sciences
national blog main
abbvie
acute hepatic porphyrias
akin akinc
akouos
allergan
amag pharmaceuticals
aminolevulinic acid
amunix
anirvan ghosh
astrazeneca
biogen
biotech
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
drugs
durvalumab
editas medicine
europe blog main
europe top stories
forty seven
fred hutch
What
acquisitions
ago
alnylam
announced
approval
bio
ceo
collabs
covid
daniel
deal
drug
fda
gilead
gilead’s
help
indicated
interference
introduce
ipo
medicine
medicines
month
nod
o’day
pharmaceuticals
plans
quick
rna
rnai
roundup
sciences
second
seek
speedy
transformative
weeks
won’t
years
Language
unset
Current search:
givosiran
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug